Judith M. Matthews, Chief Financial Officer at Iterum Therapeutics plc (ITRM), sold 47,132 shares at $0.38 ($18K) on 2022-03-14, disclosed to the SEC on 2022-03-15.
Open-market sale of $18k ITRM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ITRM | SELL | 2020-10-02 | $184K | — | Filing → |
| ITRM | BUY | 2018-05-30 | $52K | — | Filing → |